Efficacy of COLD-fX in the prevention of respiratory symptoms in community-dwelling adults: A randomized, double-blinded, placebo controlled trial

Journal of Alternative and Complementary Medicine

Volumn 12, Issue 2, 2006, Pages 153-157

  McElhaney, Janet E ^a   Goel, Vinti ^b   Toane, Benjamin ^c   Hooten, Johnathan ^d   Shan, Jacqueline J ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b CV Technologies Inc   (Canada)

^c Idylwylde Public Health Clinic   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; COLD FX; CVT E002; GINSENG EXTRACT; INFLUENZA VACCINE; PLACEBO;

ACUTE RESPIRATORY TRACT DISEASE; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; GINSENG; HUMAN; INCIDENCE; PANAX QUINQUEFOLIUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; COMMON COLD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; TREATMENT OUTCOME;

EID: 33645563441     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2006.12.153     Document Type: Article

References (14)

1. Pang PKT, Shan JJ, Chiu KW. Chemical and pharmacological standardization of herbal extracts. United States Patent # 6,156,291. Dated: December 5, 2000.
2. Wang M, Guilbert LJ, Ling L, et al. Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng (Panax quinquefolium). J Pharm Pharmacol 2001;53:1515-1523.
3. Wang M, Guilbert LJ, Li J, et al. A proprietary extract from North American ginseng (Panax quinquefolium) enhances IL-2 and IFN-γ productions in murine spleen cells induced by Con-A. Int Immunopharmacol 2004;4:311-315.
4. Almed R, Biron CA. Immunity to viruses. In: Paul WE, ed. Fundamental Immunology. Philadelphia: Raven Publishers, 1999:1303-1319.
5. McElhaney JE, Gravenstein S, Cole SK, et al. A placebo-controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults. J Am Geriatr Soc 2004;52:13-19.
6. Predy GN, Goel V, Lovlin R, et al. Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: A randomized controlled trial. CMAJ 2005;173:1043-1048.
7. Nicholson KG, Kent J, Hammersley V, Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: Comparative, prospective, population based study of disease burden. BMJ 1997;315:1060-1064.
8. Murasko DM, Nelson BJ, Matour D, et al. Heterogenity of changes in lymphoproliferative ability with increasing age. Exp Gerontol 1991;26:269.
9. Murasko DM, Weiner P, Kaye D. Decline in mitogen induced proliferation of lymphocytes with increasing age. Clin Exp Immunol 1987;70:440-448.
10. Barcellini W, Borghi MO, Sguotti C, et al. Heterogenity of immune responsiveness in healthy elderly subjects. Clin Immun Immunopath 1988;47:142-151.
11. Govaert TM, Thijs CT, Masurel N, et al. The efficacy of influenza vaccination in elderly individuals: A randomized double-blind placebo-controlled trial. JAMA 1994;272:1661-1665.
12. Jefferson T, Rivetti D, Rivetti A, et al. Efficacy and effectiveness of influenza vaccines in elderly people: A systematic review. Lancet 2005;366:1165-1174.
13. Crighton EJ, Moineddin R, Mamdani M, Upshur RE. Influenza and pneumonia hospitalizations in Ontario: A time-series analysis. Epidemiol Infect 2004;132:1167-1174.
14. Cohen S, Hamrick N, Rodriguez MS, et al. Reactivity and vulnerability to stress-associated risk for upper respiratory illness. Psychosom Med 2002;64:302-310.